Fasting Study of Escitalopram Oxalate Tablets 20 mg and Lexapro® Tablets 20 mg

NCT00648570 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Escitalopram Oxalate Tablets 20 mg
DRUG: Lexapro® Tablets (20 mg

Sponsor

Mylan Pharmaceuticals Inc